MEDICINES FOR LIFE

Serial Number 75319264
606

Registration Progress

Application Filed
Jul 3, 1997
Under Examination
Aug 18, 1998
Approved for Publication
Apr 24, 1998
Published for Opposition
May 26, 1998
Registered

Trademark Image

MEDICINES FOR LIFE

Basic Information

Serial Number
75319264
Filing Date
July 3, 1997
Published for Opposition
May 26, 1998
Abandonment Date
February 19, 2001
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 19, 2001
Classes
005 042

Rights Holder

Lung RX, Inc.

03
Address
1826 R Street, N.W.
Washington, DC 20009

Ownership History

Lung RX, Inc.

Original Applicant
03
Washington, DC

Lung RX, Inc.

Owner at Publication
03
Washington, DC

Legal Representation

Attorney
PAUL A MAHON

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

18 events
Date Code Type Description Documents
Mar 24, 2001 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 20, 2000 EX4G S SOU EXTENSION 4 GRANTED Loading...
Aug 18, 2000 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 20, 2000 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Feb 17, 2000 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Sep 13, 1999 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 13, 1999 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 13, 1999 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 12, 1999 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 5, 1999 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 19, 1999 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 18, 1998 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 26, 1998 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 24, 1998 NPUB O NOTICE OF PUBLICATION Loading...
Mar 18, 1998 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 26, 1998 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 11, 1998 CNRT F NON-FINAL ACTION MAILED Loading...
Feb 3, 1998 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of chronic conditions, namely, chronic liver disease, chronic central nervous system disease, chronic gastroenterological disease, metastatic cancer
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
develop and implement innovative medical therapies
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042